RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $126,000 | -25.0% | 77,335 | -63.4% | 0.00% | – |
| Q2 2022 | $168,000 | -59.5% | 211,536 | -8.3% | 0.00% | – |
| Q1 2022 | $415,000 | +4.0% | 230,664 | -1.2% | 0.00% | – |
| Q4 2021 | $399,000 | -34.5% | 233,408 | -21.1% | 0.00% | -100.0% |
| Q3 2021 | $609,000 | -27.2% | 295,769 | -18.4% | 0.00% | 0.0% |
| Q2 2021 | $837,000 | -24.3% | 362,326 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $1,106,000 | -49.0% | 396,584 | -47.9% | 0.00% | -50.0% |
| Q4 2020 | $2,169,000 | +25.2% | 761,064 | -7.7% | 0.00% | 0.0% |
| Q3 2020 | $1,732,000 | -38.3% | 824,966 | +33.6% | 0.00% | -33.3% |
| Q2 2020 | $2,809,000 | -21.5% | 617,400 | +41.0% | 0.00% | -50.0% |
| Q1 2020 | $3,577,000 | -39.3% | 437,798 | +36.3% | 0.01% | -14.3% |
| Q4 2019 | $5,889,000 | – | 321,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |